Sweden · Delayed Price · Currency is SEK Humana AB Statistics
Total Valuation
Humana AB has a market cap or net worth of SEK 2.31 billion. The enterprise value is 6.67 billion.
| Market Cap | 2.31B |
| Enterprise Value | 6.67B |
Important Dates
The next estimated earnings date is Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Humana AB has 49.22 million shares outstanding. The number of shares has increased by 3.09% in one year.
| Current Share Class | 49.22M |
| Shares Outstanding | 49.22M |
| Shares Change (YoY) | +3.09% |
| Shares Change (QoQ) | -0.84% |
| Owned by Insiders (%) | 2.37% |
| Owned by Institutions (%) | 24.37% |
| Float | 28.28M |
Valuation Ratios
The trailing PE ratio is 9.91 and the forward PE ratio is 8.47.
| PE Ratio | 9.91 |
| Forward PE | 8.47 |
| PS Ratio | 0.23 |
| PB Ratio | 0.70 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.73 |
| P/OCF Ratio | 2.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.10, with an EV/FCF ratio of 13.66.
| EV / Earnings | 27.77 |
| EV / Sales | 0.65 |
| EV / EBITDA | 6.10 |
| EV / EBIT | 13.23 |
| EV / FCF | 13.66 |
Financial Position
The company has a current ratio of 0.69, with a Debt / Equity ratio of 1.37.
| Current Ratio | 0.69 |
| Quick Ratio | 0.65 |
| Debt / Equity | 1.37 |
| Debt / EBITDA | 4.13 |
| Debt / FCF | 9.25 |
| Interest Coverage | 2.02 |
Financial Efficiency
Return on equity (ROE) is 7.42% and return on invested capital (ROIC) is 3.85%.
| Return on Equity (ROE) | 7.42% |
| Return on Assets (ROA) | 3.15% |
| Return on Invested Capital (ROIC) | 3.85% |
| Return on Capital Employed (ROCE) | 6.87% |
| Revenue Per Employee | 586,462 |
| Profits Per Employee | 13,779 |
| Employee Count | 13,386 |
| Asset Turnover | 1.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana AB has paid 56.00 million in taxes.
| Income Tax | 56.00M |
| Effective Tax Rate | 18.73% |
Stock Price Statistics
The stock price has increased by +25.03% in the last 52 weeks. The beta is 0.23, so Humana AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +25.03% |
| 50-Day Moving Average | 45.20 |
| 200-Day Moving Average | 41.31 |
| Relative Strength Index (RSI) | 53.32 |
| Average Volume (20 Days) | 110,546 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Humana AB had revenue of SEK 10.22 billion and earned 240.00 million in profits. Earnings per share was 4.74.
| Revenue | 10.22B |
| Gross Profit | 2.17B |
| Operating Income | 504.00M |
| Pretax Income | 299.00M |
| Net Income | 240.00M |
| EBITDA | 221.00M |
| EBIT | 504.00M |
| Earnings Per Share (EPS) | 4.74 |
Balance Sheet
The company has 298.00 million in cash and 4.51 billion in debt, giving a net cash position of -4.22 billion or -85.66 per share.
| Cash & Cash Equivalents | 298.00M |
| Total Debt | 4.51B |
| Net Cash | -4.22B |
| Net Cash Per Share | -85.66 |
| Equity (Book Value) | 3.30B |
| Book Value Per Share | 64.15 |
| Working Capital | -659.00M |
Cash Flow
In the last 12 months, operating cash flow was 787.00 million and capital expenditures -299.00 million, giving a free cash flow of 488.00 million.
| Operating Cash Flow | 787.00M |
| Capital Expenditures | -299.00M |
| Free Cash Flow | 488.00M |
| FCF Per Share | 9.92 |
Margins
Gross margin is 21.23%, with operating and profit margins of 4.93% and 2.35%.
| Gross Margin | 21.23% |
| Operating Margin | 4.93% |
| Pretax Margin | 2.93% |
| Profit Margin | 2.35% |
| EBITDA Margin | 2.16% |
| EBIT Margin | 4.93% |
| FCF Margin | 4.78% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.13%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 20.83% |
| Buyback Yield | -3.09% |
| Shareholder Yield | -0.97% |
| Earnings Yield | 10.39% |
| FCF Yield | 21.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Humana AB has an Altman Z-Score of 1.65 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 6 |